65 citations
,
September 2017 in “British Journal of Cancer”
Black ethnicity, prior PSA tests, enlarged prostate, and familyhistory increase prostatecancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.
A dermatologist advised a patient to stop taking finasteride (fin) after turning 40 due to potential risk of aggressive prostatecancer. The patient and others in the conversation debated this advice, discussing the relationship between finasteride, prostatecancer, and hair loss, and considering alternatives like topical finasteride.
A woman is concerned about her husband's hair thinning and researches treatments like finasteride and minoxidil. He decides against medication due to potential side effects and plans to shave his head if necessary.
Finasteride and dutasteride are discussed as preventative treatments for hair loss, with some advocating for early use and others concerned about side effects, especially before full maturity. Many regret not starting these treatments earlier due to their effectiveness in preventing or slowing hair loss.
The conversation discusses hair regrowth progress using 1mg oral finasteride and 5mg oral minoxidil daily over three years. Concerns about potential heart risks from minoxidil dosage are raised, with suggestions to consult a doctor and consider reducing the dose.
Finasteride made the original poster feel better, with increased energy and less frequent urination, but they were advised to see a doctor due to potential prostate issues. Some users reported positive effects like increased libido and reduced anxiety, while others experienced negative side effects like brain fog and erectile dysfunction.